1980-2001 Controls 2002+ Epidemiology Geier & Geier ASD 53 Maternal Significant dose-response RhoGAM [117] Controls 926 relationship between the J Matern Fetal severity of the regressive Neonatal Med ASD 1987-2001 RhoGAM ASDs and total mercury Controls dose children received from RhoGAM RhoGAM=Rho (D) Immune Globulin; NDs= neurodevelopmental disorders Table 13. Epidemiological Studies that did Show Thimerosal in RhoGam is a Risk Factor for ASD not Type of Study Authors and N Purpose of Study Findings Source of Journal Exposure Age or Time Epidemiology Miles and ASD 214 Association between No association was RhoGam Takahashi [118] Rh status, RhoGam found between Am J Med Genet Children use in and maternal RhoGam A diagnosed autism use and autism RhoGAM=Rho (D) Immune Globulin;
1980-2001 Controls 2002+ Epidemiology RhoGAM Geier & Geier [117] J Matern Fetal Neonatal Med ASD 53 Controls 926 ASD 1987-2001 Controls Maternal RhoGAM Significant dose-response relationship between the severity of the regressive ASDs and total mercury dose children received from RhoGAM RhoGAM=Rho (D) Immune Globulin; NDs= neurodevelopmental disorders Table 13. Epidemiological Studies that did not Show Thimerosal in RhoGam is a Risk Factor for ASD Type of Study Source of Exposure Authors and Journal N Age or Time Purpose of Study Findings Epidemiology RhoGam Miles and Takahashi [118] Am J Med Genet A ASD 214 Children diagnosed Association between Rh status, RhoGam use in and autism No association was found between maternal RhoGam use and autism RhoGAM=Rho (D) Immune Globulin;
1-s2.0-S0946672X16300931-mmc1.docx